Cambridge Cognition Holdings Plc(COG)
GBX --+0.00%
Reward50Moderate
Risk63Medium-High
📊75%Data
Thin -18% profit margin
COG
+0.0 · +0.00%
GBX · LSE
Cambridge Cognition Holdings Plc | Healthcare
Value Trap
Market Cap:16.29M
ℹ️
Reward Rating
50
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
63
Medium-High
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on COG to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: 56p.

What is Cambridge Cognition Holdings Plc?

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally.

COG · Verdict

Moderate reward · elevated risk

COG's standout is valuation; cash flow and profitability weigh on the picture.

Based on 88% data coverage

COG · Verdict

What’s working & what to watch

Strengths 1

  • Valuation77/100

    P/E 11.8× · PEG 0.01

Watchouts 3

  • Cash flow25/100

    -3% free-cash-flow margin

  • Profitability32/100

    -18% net margin · -53% ROE

  • Balance sheet44/100

    Current ratio 0.40

Model-based scoring. For information only — not financial advice.

What is Cambridge Cognition Holdings Plc?

Cambridge Cognition Holdings Plc develops and markets digital solutions for the assessment of brain health in the United States, United Kingdom, the European Union, and internationally. The company offers digital cognitive assessments, including the CANTAB cognitive assessment battery, which measures cognitive function correlated to neural networks; a voice analysis platform, an automated speech assessment tool that provides real-time scoring for cognitive performance; and high frequency testing, which detects fluctuations in brain health with short tasks over regular timepoints. The company is listed on the LSE in UK, operating in the Healthcare sector, with a market capitalisation of 16.29M.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Moderate volatility with meaningful macro and earnings sensitivity.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (50)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are elevated — volatility and macro sensitivity warrant consideration.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap16.29M
P/E RatioN/A
Dividend YieldN/A
52 Week High45
52 Week Low23.9
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares Outstanding47M
No. of Employees74
IndustryHealth Information Services
ExchangeLSE
Beta0.832
CurrencyGBX · Reports in GBP